Elevance Health (ELV) Cash & Current Investments (2009 - 2026)

Elevance Health (ELV) has 18 years of Cash & Current Investments data on file, last reported at $36.0 billion in Q2 2026.

• On a quarterly basis, Cash & Current Investments rose 278.67% year-over-year to $36.0 billion in Q2 2026; TTM through Jun 2026 was $36.0 billion, a 278.67% increase from a year earlier, with the FY2025 full-year figure at $10.2 billion, up 7.92% from the prior year.
• Cash & Current Investments for Q2 2026 stood at $36.0 billion, up from $35.6 billion in the prior quarter.
• Over the last five years, Cash & Current Investments for ELV reached as high as $36.0 billion in Q2 2026 and fell as low as $6.7 billion in Q1 2024.
• Historically, Cash & Current Investments has averaged $13.3 billion across 5 years, with a median of $9.5 billion in 2024.
• Across the five-year window, Cash & Current Investments plunged 76.91% in 2022 and soared 332.89% in 2026, its largest moves.
• Year by year, Cash & Current Investments stood at $8.3 billion in 2022, then slipped by 19.0% to $6.8 billion in 2023, then soared by 40.34% to $9.5 billion in 2024, then rose by 7.92% to $10.2 billion in 2025, then jumped by 251.39% to $36.0 billion in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $36.0 billion in Q2 2026, $35.6 billion in Q1 2026, and $10.2 billion in Q4 2025.